UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q 

 

(Mark one) 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

 

For the transition period from ____________ to __________

 

Commission File Number: 333-180954 

 

HAWKEYE SYSTEMS, INC. 

(Exact name of registrant as specified in its charter) 

 

Nevada

 

83-0799093

(State or other jurisdiction of

incorporation or organization) 

 

(I.R.S. Employer 

Identification No.) 

 

6605 Abercorn, Suite 204

SavannahGA 31405

(Address of principal executive offices (Zip Code) 

 

(912) 253-0375 

Registrant’s telephone number, including area code  

 

____________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act

 

Title of Each Class

 

Trading Symbol(s)

 

Name of each Exchange on which registered

N/A

 

N/A

 

N/A

 

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes     ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Non-accelerated Filer

Accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Yes     ☐ No

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No

 

The number of shares outstanding of each of the issuer’s classes of common equity as of April 29, 2024, was 8,661,772 shares of common stock.

 

 

  

TABLE OF CONTENTS

 

 

 

 

Page

 

Part 1

FINANCIAL INFORMATION

 

3

 

 

 

 

 

 

Item 1

Financial Statements (unaudited)

 

3

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets as of March 31, 2024, (unaudited) and June 30, 2023 (audited)

 

3

 

 

 

 

 

 

 

Condensed Consolidated Statements of Operations for the three months and nine months ended March 31, 2024 and 2023 (unaudited)

 

4

 

 

 

 

 

 

 

Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months and nine months ended March 31, 2024 and 2023 (unaudited)

 

5

 

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2024 and 2023 (unaudited)

 

6

 

 

 

 

 

 

 

Notes to the Unaudited Condensed Consolidated Financial Statements

 

7

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

14

 

 

 

 

 

 

Item 4.

Controls and Procedures

 

17

 

 

 

 

 

 

Part II.

OTHER INFORMATION

 

18

 

 

 

 

 

 

Item 1

Legal Proceedings

 

18

 

 

 

 

 

 

Item 1A

Risk Factors

 

18

 

 

 

 

 

 

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

 

18

 

 

 

 

 

 

Item 3

Defaults Upon Senior Securities

 

18

 

 

 

 

 

 

Item 4

Mine Safety Disclosures

 

18

 

 

 

 

 

 

Item 5

Other Information

 

18

 

 

 

 

 

 

Item 6

Exhibits

 

19

 

 

 

 

 

 

 

SIGNATURES

 

20

 

 

 
2

Table of Contents

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

(Unaudited)

March 31,

 

 

(Audited)

June 30,

 

 

 

2024

 

 

2023

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash

 

$58

 

 

$143,861

 

Prepaid expenses

 

 

6,250

 

 

 

2,370

 

Interest receivable

 

 

143,995

 

 

 

40,438

 

Loan receivable

 

 

1,563,000

 

 

 

800,000

 

Total current assets

 

 

1,713,303

 

 

 

986,669

 

 

 

 

 

 

 

 

 

 

Total assets

 

$1,713,303

 

 

$986,669

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities – related party

 

$386,131

 

 

$730,454

 

Accounts payable and accrued liabilities

 

 

25,801

 

 

 

13,644

 

Convertible note payable, net of discount - related party

 

 

500,000

 

 

 

500,000

 

Accrued interest – related party

 

 

593,150

 

 

 

298,158

 

Line of credit – related party

 

 

570,250

 

 

 

525,000

 

Promissory note payable – related party

 

 

1,708,000

 

 

 

1,000,000

 

Total current liabilities

 

 

3,783,332

 

 

 

3,067,256

 

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

 

Loan payable due to Eagle - JV partner

 

 

442,251

 

 

 

442,251

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

 

4,225,583

 

 

 

3,509,507

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies (Note -13)

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Stockholders’ deficit:

 

 

 

 

 

 

 

 

Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding

 

 

-

 

 

 

-

 

Common stock, $0.0001 par value, 400,000,000 shares authorized; 8,661,772 and 5,552,222 shares issued and outstanding, respectively

 

 

866

 

 

 

555

 

Additional paid-in capital

 

 

10,082,311

 

 

 

9,585,094

 

Accumulated deficit

 

 

(12,595,457 )

 

 

(12,108,487 )

Total stockholders’ deficit

 

 

(2,512,280 )

 

 

(2,522,838 )

Total liabilities and stockholders’ deficit

 

$1,713,303

 

 

$986,669

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
3

Table of Contents

 

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

$14,250

 

 

$19,136

 

 

$52,015

 

 

$68,102

 

Management compensation

 

 

12,000

 

 

 

111,250

 

 

 

201,417

 

 

 

333,802

 

Professional fees

 

 

13,974

 

 

 

12,538

 

 

 

87,103

 

 

 

92,413

 

Professional fees - related party

 

 

-

 

 

 

250,000

 

 

 

-

 

 

 

292,415

 

Total operating expenses

 

 

40,224

 

 

 

392,924

 

 

$340,535

 

 

$786,732

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(40,224 )

 

 

(392,924 )

 

$(340,535 )

 

$(786,732 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense), net:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Other income

 

 

15,000

 

 

 

5,000

 

 

 

45,000

 

 

 

5,000

 

Interest income

 

 

27,102

 

 

 

10,521

 

 

 

103,556

 

 

 

10,521

 

Interest expense - related party

 

 

(101,348 )

 

 

(50,308 )

 

 

(294,991 )

 

 

(137,888 )

Total other income (expense), net

 

 

(59,246 )

 

 

(34,787 )

 

 

(146,435 )

 

 

(122,367 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss before income taxes provision

 

 

(99,470 )

 

 

(427,711 )

 

 

(486,970 )

 

$(909,099 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income tax

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$(99,470 )

 

$(427,711 )

 

$(486,970 )

 

$(909,099 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per common share - basic and diluted

 

$(0.01 )

 

$(0.10 )

 

$(0.08 )

 

$(0.22 )

Weighted average common shares outstanding - basic and diluted

 

 

7,909,883

 

 

 

4,227,142

 

 

 

6,332,408

 

 

 

4,062,935

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
4

Table of Contents

 

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(Unaudited)

 

For the Nine Months ended March 31, 2024

 

 

 

 

 

 

 

 

 

Additional

 

 

Stock

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

To Be

 

 

Accumulated

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Issued

 

 

Deficit

 

 

Total

 

Balance, June 30, 2023

 

 

5,552,223

 

 

$555

 

 

$9,585,094

 

 

$-

 

 

$(12,108,487 )

 

$(2,522,838 )

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

(214,247 )

 

 

(214,247 )

Balance, September 30, 2023

 

 

5,552,223

 

 

$555

 

 

$9,585,094

 

 

$-

 

 

$(12,322,734 )

 

$(2,737,085 )

Common stock issued for settlement of management compensation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

497,528

 

 

 

-

 

 

 

497,528

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(173,254 )

 

 

(173,254 )

Balance, December 31, 2023

 

 

5,552,223

 

 

$555

 

 

$9,585,094

 

 

$497,528

 

 

$(12,495,987 )

 

$(2,412,810 )

Common stock issued for settlement of management compensation

 

 

3,109,549

 

 

 

311

 

 

 

497,217

 

 

 

(497,528)

 

 

-

 

 

 

-

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(99,470)

 

 

(99,470)

Balance, March 31, 2024

 

 

8,661,772

 

 

$866

 

 

$10,082,311

 

 

$-

 

 

$(12,595,457)

 

 

(2,512,280)

 

For the Nine Months ended March 31, 2023

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Accumulated

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

Balance, June 30, 2022

 

 

2,560,416

 

 

$256

 

 

$8,778,391

 

 

$(10,882,176 )

 

$(2,103,529 )

Common stock issued for common stock payable

 

 

1,666,667

 

 

 

167

 

 

 

594,177

 

 

 

-

 

 

 

594,344

 

Stock based compensation – options

 

 

-

 

 

 

-

 

 

 

5,159

 

 

 

-

 

 

 

5,159

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(215,096 )

 

 

(215,096 )

Balance, September 30, 2022

 

 

4,227,083

 

 

$423

 

 

$9,377,727

 

 

$(11,097,272 )

 

$(1,719,122 )

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(266,292 )

 

 

(266,292 )

Balance, December 31, 2022

 

 

4,227,083

 

 

$423

 

 

$9,377,727

 

 

$(11,363,564 )

 

$(1,985,414 )

Shares issued for rounding to reflect the 1 for 10 reverse stock split

 

 

139

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(427,711)

 

 

(427,711)

Balance, March 31, 2023

 

 

4,227,222

 

 

$423

 

 

$9,377,727

 

 

$(11,791,275)

 

$(2,413,125)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
5

Table of Contents

 

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Nine Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$(486,970 )

 

$(909,099 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Stock based compensation – options and warrant

 

 

-

 

 

 

5,159

 

Common stock issued for settlement of compensation

 

 

497,528

 

 

 

-

 

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

-

 

 

 

(5,000)

Prepaid expense

 

 

(3,880 )

 

 

(4,592 )

Interest receivable

 

 

(103,557 )

 

 

(10,521)

Accounts payable and accrued liabilities– related party

 

 

(344,323 )

 

 

516,782

 

Accounts payable and accrued liabilities

 

 

12,157

 

 

 

8,747

 

Accrued interest - related party

 

 

294,992

 

 

 

137,889

 

Net cash used in operating activities

 

 

(134,053 )

 

 

(260,635 )

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Note receivable from CNTNR

 

 

(763,000 )

 

 

(200,000)

Net cash used in investing activities

 

 

(763,000 )

 

 

(200,000)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Net proceeds from Promissory note - related party

 

 

708,000

 

 

 

700,000

 

Net proceeds from line of credit

 

 

45,250

 

 

 

260,000

 

Net cash provided by financing activities

 

 

753,250

 

 

 

960,000

 

 

 

 

 

 

 

 

 

 

Net change in cash

 

 

(143,803 )

 

 

499,365

 

Cash beginning of period

 

 

143,861

 

 

 

325

 

Cash end of period

 

$58

 

 

$499,690

 

 

 

 

 

 

 

 

 

 

Supplemental cash flow information

 

 

 

 

 

 

 

 

Cash paid for interest

 

$-

 

 

$-

 

Cash paid for taxes

 

$-

 

 

$-

 

 

 

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

 

Common stock issued exchanged for common stock payable – related party

 

$-

 

 

$594,344

 

Common stock to be issued for settlement of service

 

$497,528

 

 

$-

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

 

 
6

Table of Contents

 

HAWKEYE SYSTEMS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2024

 

Note 1 - Summary of Significant Accounting Policies

 

Business Overview

 

Hawkeye Systems, Inc. (the “Company”), is a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. From inception until July of 2021, we focused on selling personal protective equipment (“PPE”). In July 2021, our management determined to cease the Company’s operations as a seller of PPE, deeming that continuing operations in that sector was not a productive use of our resources.

 

Our current business plan is to acquire, merge or consolidate with another company (a “target business”). We intend to use capital stock, debt or a combination of these to affect a business combination with a target business with significant growth potential. In early 2023, while actively searching for a target business, we began providing management consulting and strategic growth services to CNTNR USA, Inc., a Delaware corporation, to which we have provided a series of loans (see Note 9 “Note Receivable”).

 

Basis of presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

 

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2023, as filed with the SEC on October 17, 2023.

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.

 

Fair value measurements

 

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

 

Revenue recognition

 

As of March 31, 2024, and 2023, the Company had no revenue.

 

 
7

Table of Contents

 

Cost of sales

 

As of March 31, 2024, and 2023, the Company had no cost of sales.

 

Basic and diluted earnings per share

 

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the nine months ended March 31, 2024 and 2023, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

 

 

 

March 31,

 

 

March 31,

 

 

 

2024

 

 

2023

 

Warrants

 

 

239,401

 

 

 

239,401

 

Options

 

 

377,600

 

 

 

425,600

 

Convertible notes

 

 

7,463,082

 

 

 

6,208,130

 

Common stock payable

 

 

-

 

 

 

75,000

 

Total possible dilutive shares

 

 

8,080,083

 

 

 

6,948,129

 

 

Recent accounting pronouncements

 

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements.

 

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company has early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method.

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. In addition, an entity will have to disclose significantly more information about allowances and credit quality indicators. The new standard is effective for the Company for fiscal years beginning after December 15, 2022. The Company adopted the standard beginning in fiscal year 2023. Because the standard is still in the early stages of adoption, the Company assesses that the current adoption of the standard has not had a material impact on the Company's consolidated financial statements and will continue to monitor it as it progresses through year-end close.

 

 
8

Table of Contents

 

Note 2 - Going Concern

 

The Company’s financial statements are prepared using U.S. GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

 

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the nine months ended March 31, 2024, the Company had a net loss of $486,970, and an accumulated deficit of $12,595,457.

 

The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

 

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.

 

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Note 3 – Loan payable due to Eagle - JV partner

 

July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Membership Agreement, the interest of any net profits would be shared 33.3% among each member. If there is a loss in some or all of the capital, the Company is contingently liable to contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE.

 

In addition, the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle according to the Membership Agreement.

 

HIE did not have any operating activities since July 2021. As a result, the Company’s investment balance in HIE as of March 31, 2024 was $0, and the loan balance payable to joint venture partner Eagle totaled $442,251, unchanged since year 2021.

 

Note 4 - Related Party Transactions

 

Related party transactions are described in detail in Note 5, Note 6, Note 7, Note 8, and Note 10.

 

Note 5 – Inventory Financing Payable – related party

 

On February 19, 2021, Steve Hall, a shareholder of the Company, advanced $1 million to the Company. The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle.

 

In June 2021 the Company cancelled the contemplated purchase of inventory and returned $500,000 to Mr. Hall. Mr. Hall agreed to allow the Company to retain the balance to fund future purchases and general operating expenses.

 

 
9

Table of Contents

 

On October 1, 2021, the Company and Steve Hall entered into a restated and amended promissory note, to consolidate and restate the terms pursuant to which Steve Hall had provided funds to the Company (the “Consolidated Note”). The Consolidated Note consolidated and restated the terms of advances made on February 17, 2021, for $500,000 for inventory financing, February 18, 2021, for $500,000 for inventory financing, November 12, 2021, for $30,000 and December 13, 2021, for $75,000. In addition to consolidating the advances singled out above, the Consolidated Note included the extension of a line of credit of up to $1,000,000, from Steve Hall to the Company. The principal amount of the Consolidated Note, excluding the $1,000,000 line of credit, is $1,105,000, payable on demand at any time after October 1, 2022 (the “Due Date”), and accruing interest at a rate of 12% per year, if repaid within 90 days of the Due Date and 20% if repaid thereafter. Principal and interest due under the line of credit extended pursuant to the Consolidated Note shall be added to the principal amount due under the Consolidated Note and shall be payable pursuant to the same terms. The line of credit is due and payable on the Due Date unless extended. At the option of the holder, the Consolidated Note is convertible, at any time, into shares of common stock at a conversion price of $0.02 per share.

 

The Consolidated Note’s Due Date was extended to September 30, 2023 and, as of the date of this report, even though the Consolidated Note is in default, we have not received any notice from Steve Hall indicating his intention to collect or convert the principal and interest under the Consolidated Note.

 

As of March 31, 2024, and 2023, the accrued interest under the Consolidated Note was $240,274, and $140,000, and the principal balance was $500,000 at the end of both years, respectively.

 

Note 6 – Line of Credit – related party

 

On October 1, 2021, Steve Hall agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter. All principal disbursed under the line of credit will accrue interest and be payable on the same terms as principal due under the Consolidated Note (see Note 6). The line of credit expired on October 1, 2022. Subsequently, the line of credit has been orally renewed and extended with same terms and a new maturity date of October 1, 2023. Currently, the Company is working with Steve Hall on an extension on the Line of Credit.

 

As of March 31, 2024, and 2023, the outstanding principal of the line of credit totaled $570,250, and $525,000, with accrued interest balances of $182,092, and $75,566, respectively.

 

Note 7 – Promissory Notes Payable – related party

 

On March 29, 2023, Steve Hall provided the Company with a loan in the principal amount of $1,000,000, as evidenced by a promissory note with an annual interest rate of 12% per year (the “Steve Hall Note”). The purpose of the Steve Hall Note was to provide the Company with a funding source to make a follow-on investment in CNTNR USA, Inc., a Delaware corporation (“CNTNR”). On May 31, 2023 (or upon the closing of a debt financing), the Company would repay the outstanding principal balance of the Steve Hall Note to Steve Hall and transfer to him 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants as described below in Note 9 - Note Receivable.

 

As of March 31, 2024, and 2023, the outstanding loan balances were $1,708,000, and $700,000 with accrued interests of $170,783, and $2,268, respectively. The Steve Hall Note is past its maturity date. The Company is currently working with Mr. Hall to restructure the Steve Hall Note and extend its maturity date.

 

Note 8 – Accrued Expenses – related party

 

Between September 2021 to September 2022, the Company had accepted deposits in the total amount of $33,218 from Central National Gottesman, Inc., on a sale of face masks on behalf of Steve Hall, a shareholder of Hawkeye Systems, Inc. As of March 31, 2024, the deposits remain with the Company and have not been sent to Mr. Hall. In addition, there are no fixed repayment terms or any repayment arrangement on this accrued liability.

 

 
10

Table of Contents

 

Note 9 – Note Receivable

 

On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”). In the Amended CNTNR Note, the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. CNTNR further agreed to pay the Company a monthly consulting fee of $5,000 beginning on March 1, 2023 that will continue until the Principal Amount is repaid. In exchange for the consulting fee, the Company will provide management consulting and strategic growth services to CNTNR. The balance of the consulting fee is recorded as an accounts receivable. As of March 31, 2024, the accounts receivable has a zero balance.

 

The Amended CNTNR Note has an annual interest rate of 12% and matures at the earlier of September 30, 2023, or the closing of a material debt or equity financing. Upon maturity of the Amended CNTNR Note, CNTNR will pay to the Company all outstanding Principal Amount and interest, plus any outstanding consulting fee and issue the Company 10% of the issued and outstanding shares of CNTNR (equivalent to 6,170,879 shares). The CNTNR Note was informally extended by the parties to January 31, 2024. As of the issued date of this report, the terms of the extension are still being worked out.

 

Moreover, the Amended CNTNR Note includes warrant coverage of one warrant for every share issued in repayment of the Principal Amount at the closing of an intended merger between the Company and CNTNR which is equal to 6,170,879 warrants. The warrants will have a 30% discount rate to the current fair market price of the shares of CNTNR when exercised and will expire 36 months after April 6, 2023. Both the shares and warrant shares have not been issued as of March 31, 2024 and will be recorded at fair value as financing income upon issuance at settlement.

 

The interest is calculated on the total balance of the available loan of $1,000,000 starting on the date of the first transfer on February 28, 2023. As of March 31, 2024, the CNTNR Note and the Amended CNTNR Note have accrued interest of $143,995 with an outstanding principal of $1,563,000. The increase in the principal amount from $1,000,000 to $1,563,000 is due to the Company extending an additional loan of $563,000 to CNTNR on the same terms and conditions of those of the Amended CNTNR Note. The parties are currently working on amending the Amended CNTNR Note to reflect the increase on the principal amount of such the CNTNR Note.

 

Note 10 – Consulting Agreement - Related Party

 

On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services, including the supervision of the Company’s senior management, staff and all personnel, whether employees or consultants, strategic planning, property acquisitions and annual budget review. The contract period is 12 months with no option for renewal thereafter. The Company paid Steve Hall a one-time flat service fee of $250,000 on January 31, 2023. Compensation is without recourse and there is no requirement for performance of services during the term of the contract. The contract expired on December 31, 2023.

 

On December 1, 2023, Hawkeye entered into a consulting agreement with Chris Mulgrew, the Chief Financial Officer of the Company, to provide consulting services with monthly compensation of $3,500. The contract period is 12 months unless earlier terminated. Any extension of the term will be subject to mutual written agreement.

 

On December 1, 2023, Hawkeye entered into a consulting agreement with Corby Marshall, the Chief Executive Officer of the Company, to provide consulting services with monthly compensation of $500. The contract period is 12 months unless earlier terminated. Any extension of the term will be subject to mutual written agreement.

 

 
11

Table of Contents

 

Note 11 - Stockholders’ Equity

 

Stock Purchase Warrants

 

Transactions in stock purchase warrants for the three months ended March 31, 2024 are as follows:

 

 

 

Number of Warrants

 

 

Weighted Average Exercise Price

 

Balance at June 30, 2023

 

 

239,401

 

 

$1.04

 

Expired

 

 

-

 

 

 

-

 

Balance at September 30, 2023

 

 

239,401

 

 

 

1.04

 

Expired

 

 

-

 

 

 

-

 

Balance at December 31, 2023

 

 

239,401

 

 

$1.04

 

Expired

 

 

-

 

 

 

-

 

Balance at March 31, 2024

 

 

239,401

 

 

$1.04

 

 

The composition of the Company’s warrants outstanding at March 31, 2024 are as follows:

 

Exercise Price

 

 

Number of Warrants

 

 

Weighted Average Remaining Life (in years)

 

$

0.30

 

 

 

35,000

 

 

 

0.08

 

$

0.50

 

 

 

66,667

 

 

 

0.08

 

$

1.00

 

 

 

70,867

 

 

 

0.08

 

$

2.00

 

 

 

66,867

 

 

 

0.08

 

 

 

 

 

 

239,401

 

 

 

0.08

 

 

The intrinsic value of the warrants as of March 31, 2024 was $0.  

 

Stock Options

 

Transactions in stock options for the nine months ended March 31, 2024 are as follows:

 

 

 

 

 

 

Weighted

 

 

Weighted average

 

 

 

Number of

 

 

average

 

 

 remaining life

 

 

 

options

 

 

exercise price

 

 

(in years)

 

Outstanding, June 30, 2023

 

 

425,600

 

 

 

1.41

 

 

 

3.41

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding, September 30, 2023

 

 

425,600

 

 

 

1.41

 

 

 

3.16

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Exercisable, December 31, 2023

 

 

425,600

 

 

 

1.41

 

 

 

2.90

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

(48,000)

 

 

(0.49)

 

 

0.11

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Exercisable, March 31, 2024

 

 

377,600

 

 

$0.92

 

 

$3.01

 

 

During the three months ended March 31, 2024, the Company had not granted any stock options. And all stock options were vested at the fiscal year end June 30, 2023.

 

At March 31, 2024, the intrinsic value of the outstanding options was $9,000.

 

 
12

Table of Contents

 

Note 12 – Stock Reverse Split

 

Hawkeye filed a form of 8K/A on March 22, 2023 announcing the Company amended its Articles of Incorporation to effect a one-for-ten reverse stock split (the “Reverse Split”) of the Company’s common stock while par value of $0.0001 per share remain the same. The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding. As a result of the Reverse Split, the Company had 4,227,222 shares of common stock issued and outstanding on February 8, 2023. In addition, at the effective time of the Reverse Split, all common shares, warrants, options and the related financial information as filed in the Quarterly Report on Form 10-Q for the 3rd quarter of year 2023, in the Annual Report on Form 10-K filed on October 17, 2023, and this Quarterly Report on Form 10-Q for the 3rd quarter of year 2024 were retroactively restated to reflect the 1-for-10 reverse stock split for all past and current periods presented.

 

Note 13 – Commitments and Contingencies

 

On July 17, 2020, the Company entered into a Membership Agreement with Eagle and Ikon to form HIE. Under the terms and conditions of the Membership Agreement, in the event of a loss of capital of HIE, the Company shall contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE. HIE did not have operating activities during the quarter ended March 31, 2024. Detailed discussions are included in Note 3 – Loan payable due to Eagle - JV partner.

 

On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services. Transactions are described in detail in Note 10 - Consulting Agreement - Related Party.

 

On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”) of which the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. Further detailed discussions are included in Note 9 - Note Receivable.

 

Note 14 - Subsequent Events

 

Management has evaluated subsequent events through the date of these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.

 

 
13

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

 

The following discussion relates to the historical operations and financial statements of Hawkeye Systems, Inc. for the nine months and three months ended March 31, 2024.

 

Forward-Looking Statements

 

The following Management’s Discussion and Analysis should be read in conjunction with our financial statements and the related notes thereto included elsewhere in this quarterly report. The Management’s Discussion and Analysis contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect,” and the like, and/or future-tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements in this quarterly report. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the heading “Risks Factors” in our various filings with the Securities and Exchange Commission. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this quarterly report.

 

The Company is currently looking for investment opportunities into target businesses in diversified industries, such as affordable housing development, and technology applications to mitigate the effects of climate change.

 

Financial Condition and Results of Operations

 

We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue our operations.

 

We expect we will require additional capital to develop our business plan. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

 

Results of Operations

 

Nine Months Ended March 31, 2024 compared to Nine months ended March 31, 2023.

 

We had no operating revenues, and cost of sales, for the nine months ended March 31, 2024, and the nine months ended March 31, 2023. However, we generated $45,000, and 5,000 for the quarter ended March 31, 2024, and 2023 in other income from CNTNR for consulting fees due to the promissory note entered in February 2023. See further discussion on Note 10 – Note receivable.

 

Total operating expenses in the nine months ended March 31, 2024 were $340,535 compared to $786,731 for the same period in 2023. The decrease in operating expenses is primarily a result of a decrease in professional fees - related party, management compensation, and general and administrative expenses. The Company’s net loss was $486,970 for the nine months ended March 31, 2024 compared to $909,099 for the nine months ended March 31, 2023. The net loss for this period is primarily a result of operating expenses, and interest expenses. 

 

 
14

Table of Contents

 

Liquidity and Capital Resources

 

Our cash balance at March 31, 2024 was $58 compared to $499,690 at March 31, 2023. We do not believe these cash reserves are sufficient to cover our expenses for our operations for the next 12 months. We will require additional funding for our ongoing operations.

 

During our three fiscal quarters ended March 31, 2024, and 2023, we received $1,708,000, and $700,000, from a promissory note issued by a related party.

 

In addition, we intend to raise funds through the sale of equity and debt securities. If we cannot raise any additional financing prior to the expiration of the fourth quarter of 2024, we believe we will be able to obtain loans from management in the future, if necessary, but have no agreement in writing.

 

We are a smaller reporting company and have accumulated losses to date. Under a limited operations scenario to maintain our corporate existence, we believe we will require additional funds over the next 12 months to complete our regulatory reporting and filings. However, we will require maximum participation through private placements, or alternative financing to implement our business plan.

 

There are no assurances that we will be able to obtain further funds required for our continued operations. Even if additional financing is available, it may not be available on terms we find favorable. Failure to secure the needed additional financing will have an adverse effect on our ability to remain in business.

 

Plan of Operation and Funding

 

We expect that working capital requirements will continue to be funded through equity offerings, warrant exercises, and related party advances in the near future. We have no guarantees or firm commitments that the related party advances will continue in the near future.

 

Existing working capital, further advances, together with anticipated capital raises are expected to be adequate to fund our operations over the next twelve months, but there is no guarantee that we will be successful in raising enough capital, or that we will receive the cash flow required to fund our operations. We have no lines of credit with banking institutions or other bank financing arrangements, we do have a line of credit from a related party (see Note 6 to the Financial Statements). Generally, we have financed operations to date through proceeds from convertible loans.

 

Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences, or privileges senior to our common stock. Additional financing may not be available on acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to continue our operations.

 

Material Commitments

 

As of the date of this quarterly report, we have entered into various commitments on loan obligations. For a discussion of the related items, please see Notes 5 to 9 to the Financial Statements.

 

Purchase of Significant Equipment

 

We do not intend to purchase any significant equipment during the next twelve months.

 

 
15

Table of Contents

 

Off-Balance Sheet Arrangements

 

As of the date of this quarterly report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

Going Concern

 

As reflected in the accompanying financial statements, the Company had an accumulated deficit of approximately $12,595,457 at March 31, 2024 and net loss from operations of $340,535 for the nine months ended March 31, 2024.

 

We do not yet have a history of financial stability. Historically, the principal source of liquidity has been the issuance of equity securities, proceeds from convertible loans, and related party advances. In addition, the Company is in the development stage and has accumulated losses since inception. These factors raise substantial doubt about our ability to continue as a going concern.

 

Our ability to continue operations is dependent on the success of Management’s plans and raising of capital through the issuance of equity or debt securities, until such time that funds provided by operations are sufficient to fund working capital requirements.

 

We will require additional funding to finance our operations and regulatory filing obligations, as well as to identify, negotiate and materialize a business combination with a target business. We believe our current available cash may be insufficient to meet our cash needs for the near future. There can be no assurance that financing will be available in amounts or terms acceptable to us, if at all.

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.

 

Critical Accounting Policies and Estimates

 

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Item 2.

 

 
16

Table of Contents

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes of accounting principles generally accepted in the United States. In our review, we sought to find potential for material weaknesses in our financial controls, which is defined as a deficiency, or combination of deficiencies, in our accounting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Because of its inherent limitations, which include a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures, internal control over financial reporting may not prevent or detect misstatements, whether unintentional errors or fraud. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

 

Our management, consisting of Corby Marshall as Chief Executive Officer and Christopher Mulgrew as Chief Financial Officer, reviewed and evaluated the effectiveness of the Company’s internal control over disclosure controls and procedures (as such term is defined in Rules 13a-15(3) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) and financial reporting as of March 31, 2024. In making this assessment, our management used the criteria described in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), as well as the guidance provided in SEC Release 33-8809. In such an evaluation, Mr. Marshall and Mr. Mulgrew assessed daily interaction, self-assessment and other ongoing monitoring activities as evidence in the evaluation. Furthermore we sought to identify financial reporting risks, identify controls that adequately address financial reporting risks, considered entity level controls, reviewed the role of technology in our controls and reviewed the evidence available to support the assessment.

 

Based on this evaluation, our management concluded that, as of March 31, 2024, our disclosure controls and our internal controls over financial reporting were not effective in recording, processing, summarizing and reporting on a timely basis information required to be disclosed in the reports that we file or submit under the Exchange Act; and were not effective in assuring that information required to be disclosed in the reports we file or submit under the Exchange Act is actually disclosed or filed. Our management concluded that this is due to material weaknesses including (i) the Company having only two officers handling all financial transactions, (ii) lack of appropriate operational controls and consistency in providing our accounting personnel with financial information, (iii) incomplete financial statements on a daily basis and resulting errors in our underlying accounting system, (iv) lack of proper documentation of our assessment and evaluation, and (v) our determination that internal controls were ineffective due to the limited segregation of duties because of the limited management structure.

 

Changes in Internal Control over Financial Reporting.

 

There were no changes in our internal control over financial reporting that occurred during the fiscal quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
17

Table of Contents

 

PART II - OTHER INFORMATION

 

Item 1 - Legal Proceedings

 

From time to time the Company may be named in claims arising in the ordinary course of business. Currently, we are not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this quarterly report, no director, officer, or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. We are not aware of any other legal proceedings pending or that have been threatened against us or our property that, in the opinion of management, could reasonably be expected to have a material adverse effect on its business and financial condition.

 

Item 1A - Risk Factors

 

Not required for Smaller Reporting Companies.

 

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

 

No disclosure required.

 

Item 3 - Defaults Upon Senior Securities

 

No disclosure required.

 

Item 4 - Mine Safety Disclosure

 

No disclosure required.

 

Item 5 - Other Information

 

No disclosure required.

 

 
18

Table of Contents

 

Item 6 - Exhibits

 

Exhibits:

 

Exhibit

 

Description

 

 

 

31.1*

 

Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934

31.2*

 

Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934

32.1*

 

Certification of Chief Executive Officer pursuant to Section 1350

32.2**

 

Certification of Chief Financial Officer pursuant to Section 1350

101.INS

 

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document.

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB

 

Inline XBRL Taxonomy Extension Labels Linkbase Document.

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104*

 

Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

 

* Filed herewith.

** Furnished herewith.

 

 
19

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Hawkeye Systems, Inc.

 

 

 

 

 

Date: April 29, 2024

By:

/s/ Corby Marshall

 

 

 

Corby Marshall, Chief Executive Officer

 

 

 

Principal Executive Officer

 

 

 

 

 

Date: April 29, 2024

By:

/s/ Christopher Mulgrew

 

 

 

Christopher Mulgrew, Chief Financial Officer

 

 

 

Principal Financial Officer

 

 

 
20

 

nullnullnullnullv3.24.1.u1
Cover - shares
9 Months Ended
Mar. 31, 2024
Apr. 29, 2024
Cover [Abstract]    
Entity Registrant Name HAWKEYE SYSTEMS, INC.  
Entity Central Index Key 0001750777  
Document Type 10-Q  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company false  
Entity Current Reporting Status Yes  
Document Period End Date Mar. 31, 2024  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2024  
Entity Common Stock Shares Outstanding   8,661,772
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 333-180954  
Entity Incorporation State Country Code NV  
Entity Tax Identification Number 83-0799093  
Entity Address Address Line 1 6605 Abercorn  
Entity Address Address Line 2 Suite 204  
Entity Address City Or Town Savannah  
Entity Address State Or Province GA  
Entity Address Postal Zip Code 31405  
City Area Code 912  
Local Phone Number 253-0375  
Entity Interactive Data Current Yes  
v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2024
Jun. 30, 2023
Current assets:    
Cash $ 58 $ 143,861
Prepaid expenses 6,250 2,370
Interest receivable 143,995 40,438
Loan receivable 1,563,000 800,000
Total current assets 1,713,303 986,669
Total assets 1,713,303 986,669
Current liabilities:    
Accounts payable and accrued liabilities - related party 386,131 730,454
Accounts payable and accrued liabilities 25,801 13,644
Convertible note payable, net of discount - related party 500,000 500,000
Accrued interest - related party 593,150 298,158
Line of credit - related party 570,250 525,000
Promissory note payable - related party 1,708,000 1,000,000
Total current liabilities 3,783,332 3,067,256
Long-term liabilities:    
Loan payable due to Eagle - JV partner 442,251 442,251
Total liabilities 4,225,583 3,509,507
Commitments and contingencies (Note -13) 0 0
Stockholders' deficit:    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding 0 0
Common stock, $0.0001 par value, 400,000,000 shares authorized; 8,661,772 and 5,552,222 shares issued and outstanding, respectively 866 555
Additional paid-in capital 10,082,311 9,585,094
Accumulated deficit (12,595,457) (12,108,487)
Total stockholders' deficit (2,512,280) (2,522,838)
Total liabilities and stockholders' deficit $ 1,713,303 $ 986,669
v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Mar. 31, 2024
Jun. 30, 2023
CONDENSED CONSOLIDATED BALANCE SHEETS    
Preferred stock, shares par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 50,000,000 50,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, shares par value $ 0.0001 $ 0.0001
Common stock, shares authorized 400,000,000 400,000,000
Common stock, shares issued 8,661,772 5,552,222
Common stock, shares outstanding 8,661,772 5,552,222
v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:        
General and administrative $ 14,250 $ 19,136 $ 52,015 $ 68,102
Management compensation 12,000 111,250 201,417 333,802
Professional fees 13,974 12,538 87,103 92,413
Professional fees - related party 0 250,000 0 292,415
Total operating expenses 40,224 392,924 340,535 786,732
Loss from operations (40,224) (392,924) (340,535) (786,732)
Other income (expense), net:        
Other income 15,000 5,000 45,000 5,000
Interest income 27,102 10,521 103,556 10,521
Interest expense - related party (101,348) (50,308) (294,991) (137,888)
Total other income (expense), net (59,246) (34,787) (146,435) (122,367)
Net loss before income taxes provision (99,470) (427,711) (486,970) (909,099)
Provision for income tax 0 0 0 0
Net loss $ (99,470) $ (427,711) $ (486,970) $ (909,099)
Net loss per common share - basic and diluted $ (0.01) $ (0.10) $ (0.08) $ (0.22)
Weighted average common shares outstanding - basic and diluted 7,909,883 4,227,142 6,332,408 4,062,935
v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Stock to be issued
Retained Earnings (Accumulated Deficit)
Balance, shares at Jun. 30, 2022   2,560,416      
Balance, amount at Jun. 30, 2022 $ (2,103,529) $ 256 $ 8,778,391   $ (10,882,176)
Common stock issued for common stock payable, shares   1,666,667      
Common stock issued for common stock payable, amount 594,344 $ 167 594,177   0
Stock based compensation - options 5,159 0 5,159   0
Net loss (215,096) $ 0 0   (215,096)
Balance, shares at Sep. 30, 2022   4,227,083      
Balance, amount at Sep. 30, 2022 (1,719,122) $ 423 9,377,727   (11,097,272)
Balance, shares at Jun. 30, 2022   2,560,416      
Balance, amount at Jun. 30, 2022 (2,103,529) $ 256 8,778,391   (10,882,176)
Stock based compensation - options 5,159        
Net loss (909,099)        
Balance, shares at Mar. 31, 2023   4,227,222      
Balance, amount at Mar. 31, 2023 (2,413,125) $ 423 9,377,727   (11,791,275)
Balance, shares at Sep. 30, 2022   4,227,083      
Balance, amount at Sep. 30, 2022 (1,719,122) $ 423 9,377,727   (11,097,272)
Net loss (266,292) $ 0 0   (266,292)
Balance, shares at Dec. 31, 2022   4,227,083      
Balance, amount at Dec. 31, 2022 (1,985,414) $ 423 9,377,727   (11,363,564)
Net loss (427,711)       (427,711)
Shares issued for rounding to reflect the 1 for 10 reverse stock split, shares   139      
Balance, shares at Mar. 31, 2023   4,227,222      
Balance, amount at Mar. 31, 2023 (2,413,125) $ 423 9,377,727   (11,791,275)
Balance, shares at Jun. 30, 2023   5,552,223      
Balance, amount at Jun. 30, 2023 (2,522,838) $ 555 9,585,094 $ 0 (12,108,487)
Net loss (214,247)     0 (214,247)
Balance, shares at Sep. 30, 2023   5,552,223      
Balance, amount at Sep. 30, 2023 (2,737,085) $ 555 9,585,094 0 (12,322,734)
Balance, shares at Jun. 30, 2023   5,552,223      
Balance, amount at Jun. 30, 2023 (2,522,838) $ 555 9,585,094 0 (12,108,487)
Stock based compensation - options 0        
Net loss (486,970)        
Balance, shares at Mar. 31, 2024   8,661,772      
Balance, amount at Mar. 31, 2024 (2,512,280) $ 866 10,082,311 0 (12,595,457)
Balance, shares at Sep. 30, 2023   5,552,223      
Balance, amount at Sep. 30, 2023 (2,737,085) $ 555 9,585,094 0 (12,322,734)
Net loss (173,254) 0 0 0 (173,254)
Common stock issued for settlement of management compensation 497,528 $ 0 0 497,528 0
Balance, shares at Dec. 31, 2023   5,552,223      
Balance, amount at Dec. 31, 2023 (2,412,810) $ 555 9,585,094 497,528 (12,495,987)
Net loss (99,470) 0 0 0 (99,470)
Common stock issued for settlement of management compensation 0 $ 311 497,217 (497,528) 0
Common stock issued for settlement of management compensation, shares   3,109,549      
Balance, shares at Mar. 31, 2024   8,661,772      
Balance, amount at Mar. 31, 2024 $ (2,512,280) $ 866 $ 10,082,311 $ 0 $ (12,595,457)
v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (486,970) $ (909,099)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation - options and warrant 0 5,159
Common stock issued for settlement of compensation 497,528 0
Change in operating assets and liabilities:    
Accounts receivable 0 (5,000)
Prepaid expense (3,880) (4,592)
Interest receivable (103,557) (10,521)
Accounts payable and accrued liabilities- related party (344,323) 516,782
Accounts payable and accrued liabilities 12,157 8,747
Accrued interest - related party 294,992 137,889
Net cash used in operating activities (134,053) (260,635)
Cash flows from investing activities:    
Note receivable from CNTNR (763,000) (200,000)
Net cash used in investing activities (763,000) (200,000)
Cash flows from financing activities:    
Net proceeds from Promissory note - related party 708,000 700,000
Net proceeds from line of credit 45,250 260,000
Net cash provided by financing activities 753,250 960,000
Net change in cash (143,803) 499,365
Cash beginning of period 143,861 325
Cash end of period 58 499,690
Supplemental cash flow information    
Cash paid for interest 0 0
Cash paid for taxes 0 0
Non-cash investing and financing activities:    
Common stock issued exchanged for common stock payable - related party 0 594,344
Common stock to be issued for settlement of service $ 497,528 $ 0
v3.24.1.u1
Summary of Significant Accounting Policies
9 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies

Note 1 - Summary of Significant Accounting Policies

 

Business Overview

 

Hawkeye Systems, Inc. (the “Company”), is a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. From inception until July of 2021, we focused on selling personal protective equipment (“PPE”). In July 2021, our management determined to cease the Company’s operations as a seller of PPE, deeming that continuing operations in that sector was not a productive use of our resources.

 

Our current business plan is to acquire, merge or consolidate with another company (a “target business”). We intend to use capital stock, debt or a combination of these to affect a business combination with a target business with significant growth potential. In early 2023, while actively searching for a target business, we began providing management consulting and strategic growth services to CNTNR USA, Inc., a Delaware corporation, to which we have provided a series of loans (see Note 9 “Note Receivable”).

 

Basis of presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

 

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2023, as filed with the SEC on October 17, 2023.

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.

 

Fair value measurements

 

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

 

Revenue recognition

 

As of March 31, 2024, and 2023, the Company had no revenue.

Cost of sales

 

As of March 31, 2024, and 2023, the Company had no cost of sales.

 

Basic and diluted earnings per share

 

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the nine months ended March 31, 2024 and 2023, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

 

 

 

March 31,

 

 

March 31,

 

 

 

2024

 

 

2023

 

Warrants

 

 

239,401

 

 

 

239,401

 

Options

 

 

377,600

 

 

 

425,600

 

Convertible notes

 

 

7,463,082

 

 

 

6,208,130

 

Common stock payable

 

 

-

 

 

 

75,000

 

Total possible dilutive shares

 

 

8,080,083

 

 

 

6,948,129

 

 

Recent accounting pronouncements

 

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements.

 

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company has early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method.

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. In addition, an entity will have to disclose significantly more information about allowances and credit quality indicators. The new standard is effective for the Company for fiscal years beginning after December 15, 2022. The Company adopted the standard beginning in fiscal year 2023. Because the standard is still in the early stages of adoption, the Company assesses that the current adoption of the standard has not had a material impact on the Company's consolidated financial statements and will continue to monitor it as it progresses through year-end close.

v3.24.1.u1
Going Concern
9 Months Ended
Mar. 31, 2024
Going Concern  
Going Concern

Note 2 - Going Concern

 

The Company’s financial statements are prepared using U.S. GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

 

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the nine months ended March 31, 2024, the Company had a net loss of $486,970, and an accumulated deficit of $12,595,457.

 

The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

 

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.

 

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

v3.24.1.u1
Loan payable due to Eagle JV partner
9 Months Ended
Mar. 31, 2024
Loan payable due to Eagle JV partner  
Loan payable due to Eagle - JV partner

Note 3 – Loan payable due to Eagle - JV partner

 

July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Membership Agreement, the interest of any net profits would be shared 33.3% among each member. If there is a loss in some or all of the capital, the Company is contingently liable to contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE.

 

In addition, the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle according to the Membership Agreement.

 

HIE did not have any operating activities since July 2021. As a result, the Company’s investment balance in HIE as of March 31, 2024 was $0, and the loan balance payable to joint venture partner Eagle totaled $442,251, unchanged since year 2021.

v3.24.1.u1
Related Party Transactions
9 Months Ended
Mar. 31, 2024
Related Party Transactions  
Related Party Transactions

Note 4 - Related Party Transactions

 

Related party transactions are described in detail in Note 5, Note 6, Note 7, Note 8, and Note 10.

v3.24.1.u1
Inventory Financing Payable related party
9 Months Ended
Mar. 31, 2024
Inventory Financing Payable related party  
Inventory Financing Payable - related party

Note 5 – Inventory Financing Payable – related party

 

On February 19, 2021, Steve Hall, a shareholder of the Company, advanced $1 million to the Company. The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle.

 

In June 2021 the Company cancelled the contemplated purchase of inventory and returned $500,000 to Mr. Hall. Mr. Hall agreed to allow the Company to retain the balance to fund future purchases and general operating expenses.

On October 1, 2021, the Company and Steve Hall entered into a restated and amended promissory note, to consolidate and restate the terms pursuant to which Steve Hall had provided funds to the Company (the “Consolidated Note”). The Consolidated Note consolidated and restated the terms of advances made on February 17, 2021, for $500,000 for inventory financing, February 18, 2021, for $500,000 for inventory financing, November 12, 2021, for $30,000 and December 13, 2021, for $75,000. In addition to consolidating the advances singled out above, the Consolidated Note included the extension of a line of credit of up to $1,000,000, from Steve Hall to the Company. The principal amount of the Consolidated Note, excluding the $1,000,000 line of credit, is $1,105,000, payable on demand at any time after October 1, 2022 (the “Due Date”), and accruing interest at a rate of 12% per year, if repaid within 90 days of the Due Date and 20% if repaid thereafter. Principal and interest due under the line of credit extended pursuant to the Consolidated Note shall be added to the principal amount due under the Consolidated Note and shall be payable pursuant to the same terms. The line of credit is due and payable on the Due Date unless extended. At the option of the holder, the Consolidated Note is convertible, at any time, into shares of common stock at a conversion price of $0.02 per share.

 

The Consolidated Note’s Due Date was extended to September 30, 2023 and, as of the date of this report, even though the Consolidated Note is in default, we have not received any notice from Steve Hall indicating his intention to collect or convert the principal and interest under the Consolidated Note.

 

As of March 31, 2024, and 2023, the accrued interest under the Consolidated Note was $240,274, and $140,000, and the principal balance was $500,000 at the end of both years, respectively.

v3.24.1.u1
Line of Credit related party
9 Months Ended
Mar. 31, 2024
Line of Credit related party  
Line of Credit - related party

Note 6 – Line of Credit – related party

 

On October 1, 2021, Steve Hall agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter. All principal disbursed under the line of credit will accrue interest and be payable on the same terms as principal due under the Consolidated Note (see Note 6). The line of credit expired on October 1, 2022. Subsequently, the line of credit has been orally renewed and extended with same terms and a new maturity date of October 1, 2023. Currently, the Company is working with Steve Hall on an extension on the Line of Credit.

 

As of March 31, 2024, and 2023, the outstanding principal of the line of credit totaled $570,250, and $525,000, with accrued interest balances of $182,092, and $75,566, respectively.

v3.24.1.u1
Promissory notes payable related party
9 Months Ended
Mar. 31, 2024
Promissory notes payable related party  
Promissory notes payable - related party

Note 7 – Promissory Notes Payable – related party

 

On March 29, 2023, Steve Hall provided the Company with a loan in the principal amount of $1,000,000, as evidenced by a promissory note with an annual interest rate of 12% per year (the “Steve Hall Note”). The purpose of the Steve Hall Note was to provide the Company with a funding source to make a follow-on investment in CNTNR USA, Inc., a Delaware corporation (“CNTNR”). On May 31, 2023 (or upon the closing of a debt financing), the Company would repay the outstanding principal balance of the Steve Hall Note to Steve Hall and transfer to him 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants as described below in Note 9 - Note Receivable.

 

As of March 31, 2024, and 2023, the outstanding loan balances were $1,708,000, and $700,000 with accrued interests of $170,783, and $2,268, respectively. The Steve Hall Note is past its maturity date. The Company is currently working with Mr. Hall to restructure the Steve Hall Note and extend its maturity date.

v3.24.1.u1
Accrued expenses related party
9 Months Ended
Mar. 31, 2024
Accrued expenses related party  
Accrued expenses - related party

Note 8 – Accrued Expenses – related party

 

Between September 2021 to September 2022, the Company had accepted deposits in the total amount of $33,218 from Central National Gottesman, Inc., on a sale of face masks on behalf of Steve Hall, a shareholder of Hawkeye Systems, Inc. As of March 31, 2024, the deposits remain with the Company and have not been sent to Mr. Hall. In addition, there are no fixed repayment terms or any repayment arrangement on this accrued liability.

v3.24.1.u1
Note receivable
9 Months Ended
Mar. 31, 2024
Note receivable  
Note receivable

Note 9 – Note Receivable

 

On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”). In the Amended CNTNR Note, the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. CNTNR further agreed to pay the Company a monthly consulting fee of $5,000 beginning on March 1, 2023 that will continue until the Principal Amount is repaid. In exchange for the consulting fee, the Company will provide management consulting and strategic growth services to CNTNR. The balance of the consulting fee is recorded as an accounts receivable. As of March 31, 2024, the accounts receivable has a zero balance.

 

The Amended CNTNR Note has an annual interest rate of 12% and matures at the earlier of September 30, 2023, or the closing of a material debt or equity financing. Upon maturity of the Amended CNTNR Note, CNTNR will pay to the Company all outstanding Principal Amount and interest, plus any outstanding consulting fee and issue the Company 10% of the issued and outstanding shares of CNTNR (equivalent to 6,170,879 shares). The CNTNR Note was informally extended by the parties to January 31, 2024. As of the issued date of this report, the terms of the extension are still being worked out.

 

Moreover, the Amended CNTNR Note includes warrant coverage of one warrant for every share issued in repayment of the Principal Amount at the closing of an intended merger between the Company and CNTNR which is equal to 6,170,879 warrants. The warrants will have a 30% discount rate to the current fair market price of the shares of CNTNR when exercised and will expire 36 months after April 6, 2023. Both the shares and warrant shares have not been issued as of March 31, 2024 and will be recorded at fair value as financing income upon issuance at settlement.

 

The interest is calculated on the total balance of the available loan of $1,000,000 starting on the date of the first transfer on February 28, 2023. As of March 31, 2024, the CNTNR Note and the Amended CNTNR Note have accrued interest of $143,995 with an outstanding principal of $1,563,000. The increase in the principal amount from $1,000,000 to $1,563,000 is due to the Company extending an additional loan of $563,000 to CNTNR on the same terms and conditions of those of the Amended CNTNR Note. The parties are currently working on amending the Amended CNTNR Note to reflect the increase on the principal amount of such the CNTNR Note.

v3.24.1.u1
Consulting Agreement Related Party
9 Months Ended
Mar. 31, 2024
Consulting Agreement Related Party  
Consulting Agreement - Related Party

Note 10 – Consulting Agreement - Related Party

 

On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services, including the supervision of the Company’s senior management, staff and all personnel, whether employees or consultants, strategic planning, property acquisitions and annual budget review. The contract period is 12 months with no option for renewal thereafter. The Company paid Steve Hall a one-time flat service fee of $250,000 on January 31, 2023. Compensation is without recourse and there is no requirement for performance of services during the term of the contract. The contract expired on December 31, 2023.

 

On December 1, 2023, Hawkeye entered into a consulting agreement with Chris Mulgrew, the Chief Financial Officer of the Company, to provide consulting services with monthly compensation of $3,500. The contract period is 12 months unless earlier terminated. Any extension of the term will be subject to mutual written agreement.

 

On December 1, 2023, Hawkeye entered into a consulting agreement with Corby Marshall, the Chief Executive Officer of the Company, to provide consulting services with monthly compensation of $500. The contract period is 12 months unless earlier terminated. Any extension of the term will be subject to mutual written agreement.

v3.24.1.u1
Stockholders Equity
9 Months Ended
Mar. 31, 2024
Stockholders Equity  
Stockholders' Equity

Note 11 - Stockholders’ Equity

 

Stock Purchase Warrants

 

Transactions in stock purchase warrants for the three months ended March 31, 2024 are as follows:

 

 

 

Number of Warrants

 

 

Weighted Average Exercise Price

 

Balance at June 30, 2023

 

 

239,401

 

 

$1.04

 

Expired

 

 

-

 

 

 

-

 

Balance at September 30, 2023

 

 

239,401

 

 

 

1.04

 

Expired

 

 

-

 

 

 

-

 

Balance at December 31, 2023

 

 

239,401

 

 

$1.04

 

Expired

 

 

-

 

 

 

-

 

Balance at March 31, 2024

 

 

239,401

 

 

$1.04

 

 

The composition of the Company’s warrants outstanding at March 31, 2024 are as follows:

 

Exercise Price

 

 

Number of Warrants

 

 

Weighted Average Remaining Life (in years)

 

$

0.30

 

 

 

35,000

 

 

 

0.08

 

$

0.50

 

 

 

66,667

 

 

 

0.08

 

$

1.00

 

 

 

70,867

 

 

 

0.08

 

$

2.00

 

 

 

66,867

 

 

 

0.08

 

 

 

 

 

 

239,401

 

 

 

0.08

 

 

The intrinsic value of the warrants as of March 31, 2024 was $0.  

 

Stock Options

 

Transactions in stock options for the nine months ended March 31, 2024 are as follows:

 

 

 

 

 

 

Weighted

 

 

Weighted average

 

 

 

Number of

 

 

average

 

 

 remaining life

 

 

 

options

 

 

exercise price

 

 

(in years)

 

Outstanding, June 30, 2023

 

 

425,600

 

 

 

1.41

 

 

 

3.41

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding, September 30, 2023

 

 

425,600

 

 

 

1.41

 

 

 

3.16

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Exercisable, December 31, 2023

 

 

425,600

 

 

 

1.41

 

 

 

2.90

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

(48,000)

 

 

(0.49)

 

 

0.11

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Exercisable, March 31, 2024

 

 

377,600

 

 

$0.92

 

 

$3.01

 

 

During the three months ended March 31, 2024, the Company had not granted any stock options. And all stock options were vested at the fiscal year end June 30, 2023.

 

At March 31, 2024, the intrinsic value of the outstanding options was $9,000.

v3.24.1.u1
Stock Reverse Split
9 Months Ended
Mar. 31, 2024
Stock Reverse Split  
Stock Reverse Split

Note 12 – Stock Reverse Split

 

Hawkeye filed a form of 8K/A on March 22, 2023 announcing the Company amended its Articles of Incorporation to effect a one-for-ten reverse stock split (the “Reverse Split”) of the Company’s common stock while par value of $0.0001 per share remain the same. The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding. As a result of the Reverse Split, the Company had 4,227,222 shares of common stock issued and outstanding on February 8, 2023. In addition, at the effective time of the Reverse Split, all common shares, warrants, options and the related financial information as filed in the Quarterly Report on Form 10-Q for the 3rd quarter of year 2023, in the Annual Report on Form 10-K filed on October 17, 2023, and this Quarterly Report on Form 10-Q for the 3rd quarter of year 2024 were retroactively restated to reflect the 1-for-10 reverse stock split for all past and current periods presented.

v3.24.1.u1
Commitments and Contingencies
9 Months Ended
Mar. 31, 2024
Commitments and Contingencies  
Commitments and Contingencies

Note 13 – Commitments and Contingencies

 

On July 17, 2020, the Company entered into a Membership Agreement with Eagle and Ikon to form HIE. Under the terms and conditions of the Membership Agreement, in the event of a loss of capital of HIE, the Company shall contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE. HIE did not have operating activities during the quarter ended March 31, 2024. Detailed discussions are included in Note 3 – Loan payable due to Eagle - JV partner.

 

On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services. Transactions are described in detail in Note 10 - Consulting Agreement - Related Party.

 

On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”) of which the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. Further detailed discussions are included in Note 9 - Note Receivable.

v3.24.1.u1
Subsequent Events
9 Months Ended
Mar. 31, 2024
Subsequent Events  
Subsequent Events

Note 14 - Subsequent Events

 

Management has evaluated subsequent events through the date of these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.

v3.24.1.u1
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies  
Business Overview

Hawkeye Systems, Inc. (the “Company”), is a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. From inception until July of 2021, we focused on selling personal protective equipment (“PPE”). In July 2021, our management determined to cease the Company’s operations as a seller of PPE, deeming that continuing operations in that sector was not a productive use of our resources.

 

Our current business plan is to acquire, merge or consolidate with another company (a “target business”). We intend to use capital stock, debt or a combination of these to affect a business combination with a target business with significant growth potential. In early 2023, while actively searching for a target business, we began providing management consulting and strategic growth services to CNTNR USA, Inc., a Delaware corporation, to which we have provided a series of loans (see Note 9 “Note Receivable”).

Basis of presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

 

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2023, as filed with the SEC on October 17, 2023.

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

As of March 31, 2024, and 2023, the Company had no revenue.

Cost of sales

As of March 31, 2024, and 2023, the Company had no cost of sales.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the nine months ended March 31, 2024 and 2023, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

 

 

 

March 31,

 

 

March 31,

 

 

 

2024

 

 

2023

 

Warrants

 

 

239,401

 

 

 

239,401

 

Options

 

 

377,600

 

 

 

425,600

 

Convertible notes

 

 

7,463,082

 

 

 

6,208,130

 

Common stock payable

 

 

-

 

 

 

75,000

 

Total possible dilutive shares

 

 

8,080,083

 

 

 

6,948,129

 

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements.

 

In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company has early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method.

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, that changes the impairment model for most financial assets and certain other instruments. For receivables, loans and other instruments, entities will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowance for losses. In addition, an entity will have to disclose significantly more information about allowances and credit quality indicators. The new standard is effective for the Company for fiscal years beginning after December 15, 2022. The Company adopted the standard beginning in fiscal year 2023. Because the standard is still in the early stages of adoption, the Company assesses that the current adoption of the standard has not had a material impact on the Company's consolidated financial statements and will continue to monitor it as it progresses through year-end close.

v3.24.1.u1
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies  
Schedule Of potentially dilutive common stock

 

 

March 31,

 

 

March 31,

 

 

 

2024

 

 

2023

 

Warrants

 

 

239,401

 

 

 

239,401

 

Options

 

 

377,600

 

 

 

425,600

 

Convertible notes

 

 

7,463,082

 

 

 

6,208,130

 

Common stock payable

 

 

-

 

 

 

75,000

 

Total possible dilutive shares

 

 

8,080,083

 

 

 

6,948,129

 

v3.24.1.u1
Stockholders Equity (Tables)
9 Months Ended
Mar. 31, 2024
Stockholders Equity  
Schedule of transactions in stock purchase warrants

 

 

Number of Warrants

 

 

Weighted Average Exercise Price

 

Balance at June 30, 2023

 

 

239,401

 

 

$1.04

 

Expired

 

 

-

 

 

 

-

 

Balance at September 30, 2023

 

 

239,401

 

 

 

1.04

 

Expired

 

 

-

 

 

 

-

 

Balance at December 31, 2023

 

 

239,401

 

 

$1.04

 

Expired

 

 

-

 

 

 

-

 

Balance at March 31, 2024

 

 

239,401

 

 

$1.04

 

Schedule of warrants outstanding

Exercise Price

 

 

Number of Warrants

 

 

Weighted Average Remaining Life (in years)

 

$

0.30

 

 

 

35,000

 

 

 

0.08

 

$

0.50

 

 

 

66,667

 

 

 

0.08

 

$

1.00

 

 

 

70,867

 

 

 

0.08

 

$

2.00

 

 

 

66,867

 

 

 

0.08

 

 

 

 

 

 

239,401

 

 

 

0.08

 

Schedule Of Transactions in stock options

 

 

 

 

 

Weighted

 

 

Weighted average

 

 

 

Number of

 

 

average

 

 

 remaining life

 

 

 

options

 

 

exercise price

 

 

(in years)

 

Outstanding, June 30, 2023

 

 

425,600

 

 

 

1.41

 

 

 

3.41

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding, September 30, 2023

 

 

425,600

 

 

 

1.41

 

 

 

3.16

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Exercisable, December 31, 2023

 

 

425,600

 

 

 

1.41

 

 

 

2.90

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

Cancelled

 

 

(48,000)

 

 

(0.49)

 

 

0.11

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Exercisable, March 31, 2024

 

 

377,600

 

 

$0.92

 

 

$3.01

 

v3.24.1.u1
Summary of Significant Accounting Policies (Details) - shares
9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Convertible Note [Member]    
Total possible dilutive shares 7,463,082 6,208,130
Common Stock Payable [Member]    
Total possible dilutive shares   75,000
Options [Member]    
Total possible dilutive shares 377,600 425,600
Total Possible Dilutive Shares [Member]    
Total possible dilutive shares 8,080,083 6,948,129
Warrant [Member]    
Total possible dilutive shares 239,401 239,401
v3.24.1.u1
Going Concern (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Going Concern                  
Net loss $ (99,470) $ (173,254) $ (214,247) $ (427,711) $ (266,292) $ (215,096) $ (486,970) $ (909,099)  
Accumulated deficit $ (12,595,457)           $ (12,595,457)   $ (12,108,487)
v3.24.1.u1
Loan payable due to Eagle JV partner (Details Narrative) - USD ($)
1 Months Ended
Jul. 17, 2020
Mar. 31, 2024
Jun. 30, 2023
Description of membership agreement the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle    
Loan Payable   $ 442,251 $ 442,251
Profit sharing for each member, percentage 33.30%    
HIE [Member]      
Investment in HIE   $ 0  
Percentage of contingent liablility to repay origination loan and additional contribution 33.30%    
v3.24.1.u1
Inventory Financing Payable related party (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Oct. 01, 2021
Feb. 19, 2021
Jun. 30, 2021
Mar. 31, 2024
Mar. 31, 2023
Feb. 27, 2023
Inventory Financing Payable related party            
Advances from related party   $ 1,000,000        
Related party transaction description   The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle        
Repayment to related party     $ 500,000      
Description Of Business February 17, 2021, for $500,000 for inventory financing, February 18, 2021, for $500,000 for inventory financing, November 12, 2021, for $30,000 and December 13, 2021, for $75,000. In addition to consolidating the advances singled out above, the Consolidated Note included the extension of a line of credit of up to $1,000,000, from Steve Hall to the Company. The principal amount of the Consolidated Note, excluding the $1,000,000 line of credit, is $1,105,000, payable on demand at any time after October 1, 2022 (the “Due Date”), and accruing interest at a rate of 12% per year, if repaid within 90 days of the Due Date and 20% if repaid thereafter          
Common stock shares conversion price $ 0.02          
Accrued interest       $ 240,274 $ 140,000  
Principal amount       $ 500,000 $ 500,000 $ 1,000,000
v3.24.1.u1
Line of Credit related party (Details Narrative) - USD ($)
Oct. 01, 2021
Mar. 31, 2024
Mar. 31, 2023
Outstanding line of credit   $ 570,250 $ 525,000
Accrued interest payable   $ 182,092 $ 75,566
On October 1, 2021 | Line of credit related party description | Steve Hall [Member]      
Line of credit related party description agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter.    
Expiry date of line of credit October 1, 2023    
v3.24.1.u1
Promissory notes payable related party (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Mar. 29, 2023
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Promissory notes payable related party        
Promissory note payable - related party $ 1,000,000 $ 1,708,000 $ 1,000,000 $ 700,000
Annual interest rate of loan 12.00%      
Note repayment terms, description   the Company would repay the outstanding principal balance of the Steve Hall Note to Steve Hall and transfer to him 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants    
Accrued interest related party   $ 170,783   $ 2,268
v3.24.1.u1
Accrued expenses related party (Details Narrative)
9 Months Ended
Mar. 31, 2024
USD ($)
Hawkeye Systems, Inc [Member]  
Accepted deposits $ 33,218
v3.24.1.u1
Note receivable (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Feb. 28, 2023
Feb. 27, 2023
Mar. 31, 2024
Mar. 31, 2023
Advanced payment   $ 200,000    
Commitment fees rate   5.00%    
Principal amount   $ 1,000,000 $ 500,000 $ 500,000
Accrued interest     182,092 $ 75,566
CNTNR [Member]        
Advanced payment   $ 200,000    
Commitment fees rate   5.00%    
Monthly consulting fee     5,000  
Annual interest rate   12.00%    
Maturity date   Sep. 30, 2023    
Principal amount     6,170,879  
Discripiton of warrants discount   The warrants will have a 30% discount rate to the current fair market price of the shares of CNTNR when exercised and will expire 36 months after April 6, 2023    
Accrued interest     $ 143,995  
Interest amount $ 1,000,000      
Description of Extending Additional Loan     The increase in the principal amount from $1,000,000 to $1,563,000 is due to the Company extending an additional loan of $563,000 to CNTNR on the same terms and conditions of those of the Amended CNTNR Note  
v3.24.1.u1
Consulting Agreement - Related Party (Details Narrative) - USD ($)
1 Months Ended
Dec. 01, 2023
Jan. 31, 2023
Consulting Agreement [Member]    
Service fee   $ 250,000
Contract period 12 months  
Consulting Agreement With Corby Marshall [Member]    
Compensation amount, monthly $ 500  
Contract period 12 months  
Consulting Agreement With Chris Mulgrew [Member]    
Compensation amount, monthly $ 3,500  
Contract period 12 months  
v3.24.1.u1
Stockholders Equity (Details) - Stock Purchase Warrants [Member] - $ / shares
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Warrant shares, Beginning 239,401 239,401 239,401
Warrant shares, Ending 239,401 239,401 239,401
Weighted average exercise price, Beginning $ 1.04 $ 1.04 $ 1.04
Weighted average exercise price, Expired 0 0 0
Weighted average exercise price, Ending $ 1.04 $ 1.04 $ 1.04
v3.24.1.u1
Stockholders Equity (Details 1)
9 Months Ended
Mar. 31, 2024
$ / shares
shares
Warrants outsanding 1 [Member]  
Exercise Price | $ / shares $ 0.30
Number of Warrants 35,000
Weighted Average Remaining Life (in years) 29 days
Warrants outsanding 2 [Member]  
Exercise Price | $ / shares $ 0.50
Number of Warrants 66,667
Weighted Average Remaining Life (in years) 29 days
Warrants outsanding 3 [Member]  
Exercise Price | $ / shares $ 1.00
Number of Warrants 70,867
Weighted Average Remaining Life (in years) 29 days
Warrants outsanding 4 [Member]  
Exercise Price | $ / shares $ 2.00
Number of Warrants 66,867
Weighted Average Remaining Life (in years) 29 days
Warrants outsanding [Member]  
Number of Warrants 239,401
Weighted Average Remaining Life (in years) 29 days
v3.24.1.u1
Stockholders Equity (Details 2) - Stock Options [Member] - $ / shares
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Number of options, beginning balance 425,600 425,600 425,600
Number of options, Cancelled (48,000)    
Number of options, ending balance   425,600 425,600
Number of options, Exercisable 377,600 425,600 425,600
Weighted Average Exercise Price, beginning balance $ 1.41 $ 1.41 $ 1.41
Weighted Average Exercise Price, Cancelled (0.49)    
Weighted Average Exercise Price, ending balance 0.92 $ 1.41 $ 1.41
Weighted Average Exercise Price, Exercisable $ 0.92    
Weighted average remaining life, beginning 2 years 10 months 24 days 3 years 1 month 28 days 3 years 4 months 28 days
Weighted average remaining life, Cancelled 1 month 9 days    
Weighted average remaining life, ending   2 years 10 months 24 days 3 years 1 month 28 days
Weighted average remaining life, exercisable 3 years 3 days    
v3.24.1.u1
Stockholders Equity (Details Narrative)
Mar. 31, 2024
USD ($)
Warrant [Member]  
Intrinsic value of the outstanding options $ 0
Stock Options [Member]  
Intrinsic value of the outstanding options $ 9,000
v3.24.1.u1
Stock Reverse Split (Details Narrative) - $ / shares
9 Months Ended
Mar. 31, 2024
Jun. 30, 2023
Common stock par value $ 0.0001 $ 0.0001
Common stock, shares outstanding 8,661,772 5,552,222
Stock Reverse Split [Member]    
Common stock par value $ 0.0001  
Common stock, shares outstanding 4,227,222  
Description of stock reverse split The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding  
v3.24.1.u1
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Feb. 27, 2023
Mar. 31, 2024
Mar. 31, 2023
Commitments and Contingencies      
Repayment of origination loan, percentage   33.30%  
Principal amount $ 1,000,000 $ 500,000 $ 500,000
Advanced payment $ 200,000    
Commitment fee rate 5.00%    

Hawkeye Systems (QB) (USOTC:HWKED)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Hawkeye Systems (QB) Charts.
Hawkeye Systems (QB) (USOTC:HWKED)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Hawkeye Systems (QB) Charts.